Brink’s to propose NoteMachine/TestLink UK sale
Brink’s said the proposed UK divestiture does not change its expectation of $200 million in annual run-rate cost synergies within three years of closing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
The Brink’s Company (BCO) said it will propose divesting its NoteMachine/TestLink UK business in connection with the UK Competition and Markets Authority’s Phase 1 review of its agreed acquisition of NCR Atleos. The company said the review decision reflects local overlap between that UK business and NCR Atleos’ Cardtronics business. The proposed sale process is progressing, and a number of prospective buyers have expressed strong preliminary interest.
Brink’s said the potential divestiture was contemplated in previously disclosed financial metrics and does not affect its expectation of $200 million in annual run-rate cost synergies within three years of closing. It said the acquisition remains on track to close early in the first quarter of 2027.
Insights
Analyzing...
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Annual run-rate cost synergies: $200 million
Expected synergy period: Within three years
Expected acquisition closing: Early in the first quarter of 2027
3 metrics
Annual run-rate cost synergies
$200 million
Expected within three years of closing the acquisition
Expected synergy period
Within three years
After the acquisition closes
Expected acquisition closing
Early in the first quarter of 2027
NCR Atleos acquisition
Key Terms
fast-track Phase 1 procedure, annual run-rate cost synergies, divestiture, closing conditions
4 terms
fast-track Phase 1 procedure regulatory
"today’s decision under its ‘fast-track’ Phase 1 procedure"
annual run-rate cost synergies financial
"$200 million in annual run-rate cost synergies"
divestiture financial
"The potential sale of NoteMachine/TestLink UK"
Divestiture is the process of selling or getting rid of a part of a company, such as a division or asset. It often happens when a business wants to focus on its core activities or improve its finances. For investors, divestitures can signal strategic shifts or influence the company's value, affecting investment decisions.
closing conditions regulatory
"obtain required regulatory approvals and satisfy other closing conditions"
Closing conditions are specific requirements or steps that must be met before a financial deal or transaction can be finalized. They act like a checklist that ensures all necessary details are confirmed and agreed upon, giving both parties confidence that the deal is ready to be completed. Meeting these conditions is essential for the transaction to move forward smoothly and successfully.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much cost synergy does BCO expect from the NCR Atleos acquisition?
Brink’s expects $200 million in annual run-rate cost synergies within three years of closing the NCR Atleos acquisition. It said the proposed NoteMachine/TestLink UK divestiture does not affect that expectation.
When is BCO’s NCR Atleos acquisition expected to close?
Brink’s said the acquisition remains on track to close early in the first quarter of 2027.
What UK business overlap did BCO cite in the CMA review?
Brink’s said the CMA’s Phase 1 decision reflects local overlap between NoteMachine/TestLink UK and NCR Atleos’ Cardtronics business in the UK. The company also said the decision came under the CMA’s fast-track Phase 1 procedure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 30, 2026
THE BRINK’S COMPANY | ||||||||
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address and zip code of
principal executive offices)
Registrant’s telephone number, including area code: (804 ) 289-9600
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule
405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 8.01 | Other Events. | |||||||
On September 30, 2026, The Brink's Company (the "Company") issued a press release. The press release is attached as Exhibits 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the information in this Item 8.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific references in such a filing.
| Item 9.01 | Financial Statements and Exhibits. | ||||||||||
| (d) | Exhibits | ||||||||||
| 99.1 | Press Release dated September 30, 2026 issued by The Brink's Company | ||||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE BRINK’S COMPANY (Registrant) | ||||||||
| Date: September 30, 2026 | By: | /s/ Kurt B. McMaken | ||||||
| Kurt B. McMaken | ||||||||
| Executive Vice President and Chief Financial Officer | ||||||||
Exhibit 99.1
P R E S S R E L E A S E |  | ||||
Contact: Investor Relations 804.289.9709 | BRINK’S CORPORATE The Brink’s Company 1801 Bayberry Court Richmond, VA 23226-8100 USA | ||||
BRINK'S ISSUES STATEMENT ON CMA’S FAST-TRACK ANNOUNCEMENT
Company agrees to propose divestiture of NoteMachine/TestLink UK in connection with CMA review
Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027
Richmond, Va., September 30, 2026 – The Brink's Company (NYSE: BCO) (“Brink’s” or “the Company”) today issued the following statement in connection with the United Kingdom's Competition and Markets Authority ("CMA") Phase 1 decision in relation to the Company’s previously announced agreement to acquire NCR Atleos Corporation (NYSE: NATL) (“NCR Atleos”):
“The CMA’s Phase 1 decision was always contemplated as a potential outcome and reflects the local overlap between Brink’s NoteMachine/TestLink UK business and NCR Atleos’ Cardtronics business in the UK. Brink’s has engaged constructively with the CMA throughout the CMA’s Phase 1 review process, a fact which is reflected in the CMA arriving at today’s decision under its ‘fast-track’ Phase 1 procedure.
The potential sale of NoteMachine/TestLink UK was a remedy that was contemplated in the financial metrics that Brink’s has previously disclosed and does not impact the $200 million in annual run-rate cost synergies that we continue to expect to achieve within three years of closing the transaction. The proposed sale process is progressing, with a number of prospective buyers having expressed strong preliminary interest. Brink’s looks forward to continuing constructive engagement with the CMA.
Supported by the constructive engagement with the CMA and meaningful progress in the proposed divestiture, the NCR Atleos acquisition remains on track to close early in the first quarter of 2027.”
About The Brink’s Company
The Brink’s Company (NYSE: BCO) is a leading global provider of cash and valuables management, digital retail solutions, and ATM managed services. Our customers include financial institutions, retailers, government agencies, mints, jewelers and other commercial operations. Our network of operations in 51 countries serves customers in more than 100 countries. For more information, please visit our website at www.brinks.com.
Forward-Looking Statements
This release contains forward-looking information. Words such as "anticipate," "assume," "estimate," "expect," “target,” "project," "predict," "intend," "plan," "believe," "potential," "may," "should" and similar expressions may identify forward-looking information. Forward-looking information in this release includes, but is not limited to statements regarding the proposed acquisition of NCR Atleos, the anticipated divestiture of NoteMachine/TestLink UK, the timing and outcome of regulatory reviews and approvals, the expected timing of closing of the transaction, and anticipated transaction benefits and synergies. These statements are based on current expectations and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed or implied by such statements.
Forward-looking statements in this document are subject to known and unknown risks, uncertainties and contingencies, which are difficult to predict or quantify, and which could cause actual results, performance or achievements to differ materially from those that are anticipated. These risks, uncertainties and contingencies, many of which are beyond our control, include, but are not limited to: our ability to obtain required regulatory approvals and satisfy other closing conditions; the timing and terms of any divestiture transaction; the possibility that the proposed acquisition is delayed or not completed; risks related to the integration of NCR Atleos and the
realization of anticipated benefits and synergies; transaction-related costs and disruptions; and other risks described in the Company’s filings with the Securities and Exchange Commission.
This list of risks, uncertainties and contingencies is not intended to be exhaustive. Additional factors that could cause our results to differ materially from those described in the forward-looking statements can be found under "Risk Factors" in Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2025, and in the registration statement on Form S-4 filed in connection with the proposed acquisition of NCR Atleos, and in related disclosures in our other public filings with the Securities and Exchange Commission. The forward-looking information included in this document is representative only as of the date of this document and The Brink's Company undertakes no obligation to update, revise or clarify any information contained in this document or forward-looking statements that may be made from time to time on our behalf, whether as a result of new information, future events or otherwise, except as required by law.
Contacts
Investor Inquiries
Jesse Jenkins
jesse.jenkins@brinksinc.com
Media Inquiries
Kelly McNeff
(469) 549-6555
brinksmedia@brinks.com
OR
FGS Global
brinks@fgsglobal.com